ebomi
Colour theme
Sign in
Insider · CIK 0001325710

Sherman Matthew L

CIK 0001325710 Name as filed on the most recent filing

Filed as Sherman Matthew L (49)

126 transaction lines · from 49 filings · filed 2014-04-24 to 2024-02-20 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

126 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2024-02-16 Deciphera Pharmaceuticals, Inc.
DCPH 		S, Open-market sale 2,615 disposed 15.62 40,840.29 Form 4, filing 0000950170-24-017085
2024-01-16 Deciphera Pharmaceuticals, Inc.
DCPH 		S, Open-market sale 2,435 disposed 14.47 35,233.72 Form 4, filing 0000950170-24-005393
2023-12-13 Deciphera Pharmaceuticals, Inc.
DCPH 		S, Open-market sale 2,792 disposed 15.37 42,904.94 Form 4, filing 0000950170-23-070382
2023-10-30 Deciphera Pharmaceuticals, Inc.
DCPH 		S, Open-market sale 2,360 disposed 12.02 28,361.54 Form 4, filing 0001209191-23-053939
2023-10-02 Deciphera Pharmaceuticals, Inc.
DCPH 		S, Open-market sale 2,942 disposed 12.68 37,304.56 Form 4, filing 0001209191-23-051886
2023-06-16 Deciphera Pharmaceuticals, Inc.
DCPH 		S, Open-market sale 1,655 disposed 14.40 23,834.98 Form 4, filing 0001209191-23-038756
2023-02-16 Deciphera Pharmaceuticals, Inc.
DCPH 		S, Open-market sale 971 disposed 15.10 14,661.13 Form 4, filing 0001209191-23-010506
2023-01-17 Deciphera Pharmaceuticals, Inc.
DCPH 		S, Open-market sale 2,403 disposed 21.24 51,042.84 Form 4, filing 0001209191-23-003998
2022-10-03 Deciphera Pharmaceuticals, Inc.
DCPH 		S, Open-market sale 2,587 disposed 18.73 48,454.51 Form 4, filing 0001209191-22-052717
2022-06-16 Deciphera Pharmaceuticals, Inc.
DCPH 		S, Open-market sale 1,768 disposed 10.75 19,006.00 Form 4, filing 0001209191-22-038432
2022-02-16 Deciphera Pharmaceuticals, Inc.
DCPH 		S, Open-market sale 984 disposed 9.05 8,905.20 Form 4, filing 0001209191-22-011361
2021-10-04 Deciphera Pharmaceuticals, Inc.
DCPH 		S, Open-market sale 2,659 disposed 33.17 88,199.03 Form 4, filing 0001209191-21-059804
2021-02-16 Deciphera Pharmaceuticals, Inc.
DCPH 		S, Open-market sale 132 disposed 48.87 6,450.84 Form 4, filing 0001209191-21-012114
2018-04-03 Pulmatrix, Inc.
PULM 		P, Open-market purchase 20,000 acquired Not reported Not priced Form 4, filing 0000899243-18-009608
2018-04-03 Acceleron Pharma Inc
XLRN 		S, Open-market sale 3,700 disposed 38.28 141,636.00 Form 4, filing 0001179110-18-005397
2018-04-03 Acceleron Pharma Inc
XLRN 		S, Open-market sale 900 disposed 39.04 35,136.00 Form 4, filing 0001179110-18-005397
2018-01-03 Acceleron Pharma Inc
XLRN 		S, Open-market sale 2,300 disposed 42.40 97,520.00 Form 4, filing 0001179110-18-000545
2018-01-03 Acceleron Pharma Inc
XLRN 		S, Open-market sale 2,033 disposed 43.33 88,089.89 Form 4, filing 0001179110-18-000545
2018-01-03 Acceleron Pharma Inc
XLRN 		S, Open-market sale 300 disposed 40.86 12,258.00 Form 4, filing 0001179110-18-000545
2017-09-12 Acceleron Pharma Inc
XLRN 		S, Open-market sale 16,650 disposed 38.32 638,028.00 Form 4, filing 0001179110-17-012288
2017-09-12 Acceleron Pharma Inc
XLRN 		S, Open-market sale 1,600 disposed 39.24 62,784.00 Form 4, filing 0001179110-17-012288
2017-09-12 Acceleron Pharma Inc
XLRN 		S, Open-market sale 150 disposed 39.91 5,986.50 Form 4, filing 0001179110-17-012288
2017-07-05 Acceleron Pharma Inc
XLRN 		S, Open-market sale 16,000 disposed 32.00 512,000.00 Form 4, filing 0001179110-17-010224
2017-01-04 Acceleron Pharma Inc
XLRN 		S, Open-market sale 1,600 disposed 27.62 44,192.00 Form 4, filing 0001179110-17-000681
2017-01-04 Acceleron Pharma Inc
XLRN 		S, Open-market sale 400 disposed 26.81 10,724.00 Form 4, filing 0001179110-17-000681
2016-07-01 Acceleron Pharma Inc
XLRN 		S, Open-market sale 20,207 disposed 34.89 705,022.23 Form 4, filing 0001179110-16-027493
2016-07-01 Acceleron Pharma Inc
XLRN 		S, Open-market sale 5,793 disposed 34.20 198,120.60 Form 4, filing 0001179110-16-027493
2016-04-07 Acceleron Pharma Inc
XLRN 		S, Open-market sale 23,920 disposed 32.00 765,440.00 Form 4, filing 0001179110-16-022918
2016-04-06 Acceleron Pharma Inc
XLRN 		S, Open-market sale 2,080 disposed 32.00 66,560.00 Form 4, filing 0001179110-16-022918
2015-10-15 Acceleron Pharma Inc
XLRN 		S, Open-market sale 2,400 disposed 23.93 57,432.00 Form 4, filing 0001179110-15-014061
2015-10-15 Acceleron Pharma Inc
XLRN 		S, Open-market sale 2,400 disposed 22.66 54,384.00 Form 4, filing 0001179110-15-014061
2015-10-15 Acceleron Pharma Inc
XLRN 		S, Open-market sale 700 disposed 22.69 15,883.00 Form 4, filing 0001179110-15-014061
2015-10-15 Acceleron Pharma Inc
XLRN 		S, Open-market sale 500 disposed 23.94 11,970.00 Form 4, filing 0001179110-15-014061
2015-09-16 Acceleron Pharma Inc
XLRN 		S, Open-market sale 1,100 disposed 32.22 35,442.00 Form 4, filing 0001104659-15-066038
2015-09-16 Acceleron Pharma Inc
XLRN 		S, Open-market sale 400 disposed 34.96 13,984.00 Form 4, filing 0001104659-15-066038
2015-09-16 Acceleron Pharma Inc
XLRN 		S, Open-market sale 300 disposed 33.55 10,065.00 Form 4, filing 0001104659-15-066038
2015-09-16 Acceleron Pharma Inc
XLRN 		S, Open-market sale 200 disposed 34.93 6,986.00 Form 4, filing 0001104659-15-066038
2015-08-18 Acceleron Pharma Inc
XLRN 		S, Open-market sale 2,790 disposed 30.83 86,015.70 Form 4, filing 0001179110-15-012360
2015-08-18 Acceleron Pharma Inc
XLRN 		S, Open-market sale 1,400 disposed 31.00 43,400.00 Form 4, filing 0001179110-15-012360
2015-08-18 Acceleron Pharma Inc
XLRN 		S, Open-market sale 1,210 disposed 31.60 38,236.00 Form 4, filing 0001179110-15-012360
2015-08-18 Acceleron Pharma Inc
XLRN 		S, Open-market sale 800 disposed 30.99 24,792.00 Form 4, filing 0001179110-15-012360
2015-08-18 Acceleron Pharma Inc
XLRN 		S, Open-market sale 400 disposed 31.95 12,780.00 Form 4, filing 0001179110-15-012360
2015-08-18 Acceleron Pharma Inc
XLRN 		S, Open-market sale 200 disposed 31.69 6,338.00 Form 4, filing 0001179110-15-012360
2015-08-18 Acceleron Pharma Inc
XLRN 		S, Open-market sale 200 disposed 31.69 6,338.00 Form 4, filing 0001179110-15-012360
2015-07-20 Acceleron Pharma Inc
XLRN 		S, Open-market sale 3,900 disposed 32.29 125,931.00 Form 4, filing 0001179110-15-011391
2015-07-20 Acceleron Pharma Inc
XLRN 		S, Open-market sale 1,000 disposed 32.31 32,310.00 Form 4, filing 0001179110-15-011391
2015-07-20 Acceleron Pharma Inc
XLRN 		S, Open-market sale 800 disposed 33.22 26,576.00 Form 4, filing 0001179110-15-011391
2015-07-20 Acceleron Pharma Inc
XLRN 		S, Open-market sale 200 disposed 33.22 6,644.00 Form 4, filing 0001179110-15-011391
2015-07-20 Acceleron Pharma Inc
XLRN 		S, Open-market sale 100 disposed 32.74 3,274.00 Form 4, filing 0001179110-15-011391
2015-06-18 Acceleron Pharma Inc
XLRN 		S, Open-market sale 5,600 disposed 31.57 176,792.00 Form 4, filing 0001179110-15-010052

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 1
  • Open-market sale 125
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Sherman Matthew L, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001325710

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.